Final-Program-ATS-2023-AP.vp

116

SUNDAY • MAY 21

619 Pattern of Allergic Sensitization in Lagos, Nigeria: Informing Cost Effective Testing for a Low Resource Setting/ S.K. Dede, Lagos, Nigeria 620 The Conundrum of Early Childhood Asthma Treatment: Evidence From the Canadian Asthma Primary Prevention Study/ R. Li, Bloomington, IN 621 Characteristics of Patients With Moderate-to-Severe Asthma and High Healthcare Costs in the United States/ J. Hwee, Mississauga, Canada 622 Heterogeneity of Elderly Asthmatics Unveiled by Phenotyping/Endotyping of a Brazilian Sample/ M. Menezes, Ribeirao Preto, Brazil 623 Real World Investigation of Eosinophilic-associated Disease Overlap (REVEAL): Persistent Asthma Healthcare Resource Utilization and Associated Cost Sub-study/ J. Kwiatek, Wilmington, PA 624 Airway Efficacy and Systemic Activity With Different Inhaled Corticosteroid-containing Dosing Regimens in Patients With Persistent Asthma: A Structured Literature Review and Modeling Analysis/ D. Singh, Manchester, United Kingdom 625 Quality of Life in Patients With Asthma Using Oral or Inhaled Corticosteroids - a Qualitative Study/ P.N. Persaud, Cleveland, OH A102 THE DEVELOPMENT, PROGRESSION, AND TREATMENT OF ILD 2:15 p.m. - 4:15 p.m. Walter E. Washington Convention Center Room 209 A-C (Level 2) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 Chairing: G.M. Hunninghake, MPH, MD, Boston, MA A. Podolanczuk, MD, ATSF, New York, NY Y.H. Khor, BMedSci, MBBS, FRACP, PhD, Heidelberg, Australia 801 Adult Lung Function Trajectories and Future Interstitial Features/ G.Y. Liu, Chicago, IL 802 Nocturnal Hypoxemia Is Associated With Increased Risk of Disease Progression and All-cause Mortality at One and Two Year Follow Up in Patients With Fibrotic Interstitial Lung Disease/ K.J. Myall, London, United Kingdom 803 The Clinical Frailty Scale Is Associated With Mortality in Patients With Fibrotic Interstitial Lung Disease - A Multicenter Cohort Study/ S.A. Guler, Bern, Switzerland CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

604 Relative Abundance of Gram-negative Airway Microbiota Is Associated With Airway Eosinophilia and Obesity in Allergic Asthma/ V. Mcquade, Durham, NC 605 Role of Eosinophil Mitochondrial Function in Severe Eosinophilic Asthma/ J.B. Koranteng, London, United Kingdom 606 Dysregulation of Complement Pathways in the U-BIOPRED Severe Asthma Cohort/ I.M. Adcock, London, United Kingdom 607 Mouse Model of Neutrophilic Asthma Reveals an Epithelium-Lymphocyte-Neutrophil Communication Circuit Underlying Destructive Allergic Airway Neutrophilia/ A.T. Shenoy, Boston, MA 608 Neutrophilic Responses in a Subacute and Chronic Mouse Model of Pollutant-aggravated Allergic Asthma/ J. De Volder, Ghent, Belgium 609 Impact of Rhinovirus Infection and Th17 Cell Conditioning on Airway Epithelial Expression of IL-1ß, TNF- a , IL-17C and GCSF and Neutrophil Activation in T2-low Vs T2-high Asthma/ E.R. Vanderwall, Seattle, WA 610 Epithelial Immunomodulation by Aerosolized Toll-like Agonists Prevents Allergic Lung Inflammation by Reducing Th2 Polarization/ M. Ntita, Houston, TX 611 IL-13 Regulated Airway Epithelial Genes Correlate to Lung Function and Markers of T2 Asthma in Sarpiii Participants/ J.S. Boomer, St. Louis, MO 612 Rev-erb a Knockout Mice Show Exaggerated Lung Inflammation Following Acute House Dust Mite-induced Allergic Asthma/ S.K. Duraisamy, Kansas City, KS 613 Lower CC16 Expression in the Airway Is Associated With an Asthma Phenotype and Local and Systemic Type 2 Inflammatory Traits/ H. Kimura, New York, NY 614 Airway IL-1 Family Signaling Is Increased in Allergic Controls Compared to Allergic Asthmatics in Response to Allergen Challenge/ A. Haring, Charlestown, MA 615 Preventive Effects of Inhibition of Thymic Stromal Lymphopoietin on Bronchial Hyperresponsiveness and Inflammatory Cellular Pattern in an Experimental Model of Chronic Allergic Pulmonary Inflammation Exacerbated by Lipopolysaccharide/ E.A. Grencheski, Sao Paulo, Brazil 616 Serum TSLP Levels in Asthma - Relationship to Type 2 and Non-Type 2 Biomarkers/ K. Khanna, San Francisco, CA 617 Epigenetic Training of the Interleukin 6 Gene in Airway Epithelial Cells Is Central to Asthma Exacerbations/ L. Lunding, Borstel, Germany 618 Circulating Natural Killer Cell Immunophenotypes Correlate With Severe Asthma Clinical Traits/ M.G. Duvall, Boston, MA

ATS 2023 • Washington, DC